Fuisz llc Announces Induction of Richard C. Fuisz, M.D., into Georgetown University’s 1789 Society.
MIAMI, March 21, 2013 /PRNewswire/ — Fuisz llc announced the induction of Richard C. Fuisz, M.D., into Georgetown University’s 1789 Society.
The induction statement, signed by University President Jack DeGioia read as follows: “A prolific inventor, visionary inventor and dedicated philanthropist, Richard C. Fuisz, M.D. (C’61, M’65), has distinguished himself as an alumnus of Georgetown College and Georgetown School of Medicine…. Dr. Fuisz’s longstanding support of the university —particularly for the School of Medicine and Georgetown Lombardi Comprehensive Cancer Center – has greatly strengthened teaching, research and patient care at Georgetown.”
Georgetown University’s 1789 Society is for donors who contribute $1 million or more to the university are members of the 1789 Society, named for the year in which the university was founded. They are honored for their generosity at the spring semester faculty convocation (http://giving.georgetown.edu/recognitionsocieties/).
Fuisz LLC is a private technology company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery including orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, as well as independently developing extruded sheet technology and diagnostic applications. Fuisz has extensive experience working with big and specialty pharma, as well as large consumer products companies. Fuisz has its headquarters in Miami. www.fuisz.com
SOURCE Fuisz LLC